As of May 6, 2025, NewGenIvf Group Limited's market capitalization has reached $601,269. According to our data, NewGenIvf Group Limited is the 47473th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap
601,269
Revenue (ttm)
5.43 M
Net Income (ttm)
-524,643
Shares Out
169,850
EPS (ttm)
-14.65
Forward PE
0.00
Ex-Dividend Date
n/a
Earnings Date
n/a
Market Cap Chart
Data Updated: May 6, 2025
NewGenIvf Group Limited's yearly market capitalization.
NewGenIvf Group Limited has seen its market value drop from $88.68 M to $601,269 since 2022, representing a total decrease of 99.32% and an annual compound decline rate (CAGR) of 88.06%.
Date
Market Cap
Change (%)
May 6, 2025
$601,269
-90.71%
December 31, 2024
$5.51 M
-86.45%
December 29, 2023
$40.62 M
-54.2%
December 30, 2022
$88.68 M
Company Profile
NewGenIvf Group Limited was founded in 2011 in Hong Kong.
on the Nasdaq Stock Market.
With 76 employees, it focuses on Healthcare and aims to drive innovation in Medical Care Facilities.
Frequently Asked Questions
As of May 6, 2025, NewGenIvf Group Limited (including the parent company, if applicable) has an estimated market capitalization of $601,269 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
NewGenIvf Group Limited global market capitalization ranking is approximately 47473 as of May 6, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.